For UK Residents Only

Patient Website

Sanofi Genzyme is the speciality care global business unit of Sanofi, focussed on immunology, multiple sclerosis, oncology, rare diseases and rare blood disorders.

Sanofi Genzyme Oncology believe that people with cancer and their healthcare providers deserve more - more options, more support and more life. We are striving to build a future where everyone receives the cancer support that is best for them, everyone has access to the treatments that are right for them and everyone has the best possible chance to grow old.

Report an Adverse Event

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at By reporting side effects, you can help provide more information on the safety of this medicine.

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects that you may get. See for how to report side effects.

MAT-GB-2002945 (v6.0)
Date of Preparation - July 2022